Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
57,417,494
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
47,874,920
-
Shares change
-
+2,009,982
-
Total reported value, excl. options
-
$2,335,182,718
-
Value change
-
+$99,684,851
-
Put/Call ratio
-
9.51%
-
Number of buys
-
95
-
Number of sells
-
-80
-
Price
-
$48.77
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) as of Q2 2022
197 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share as of Q2 2022.
Harmony Biosciences Holdings, Inc. - Common Stock, $0.00001 par value per share (HRMY) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,874,920 shares
of 57,417,494 outstanding shares and own 83.38% of the company stock.
Largest 10 shareholders include Valor Management LLC (11,218,033 shares), FMR LLC (5,426,782 shares), Vivo Capital, LLC (4,093,785 shares), BlackRock Inc. (3,972,879 shares), VANGUARD GROUP INC (2,964,498 shares), venBio Partners LLC (1,448,720 shares), JANUS HENDERSON GROUP PLC (1,425,168 shares), Blackstone Inc. (1,048,951 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,034,450 shares), and STATE STREET CORP (944,335 shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.